Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Lithuania Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20042
20054
20061
20075
20085
200913
20105
20114
20126
20132
20143
20152
20161
20171
20183
20191
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated12
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
Takeda8
AstraZeneca7
Boehringer Ingelheim6
Eli Lilly and Company5
GlaxoSmithKline4
Hoffmann-La Roche4
Novartis Pharmaceuticals4
Novo Nordisk A/S4
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 264
Diabetes Mellitus12
Cardiovascular Diseases6
Diabetic Nephropathies4
Glucose Metabolism Disorders4
Heart Failure4
Hyperglycemia4
Renal Insufficiency, Chronic4
Dyslipidemias3
Diabetes Mellitus, Lipoatrophic2

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.